PepGen Inc. PEPG 深 滬
已收盤 10-10 16:00:00 美东时间
4.715
-0.315
-6.26%
華盛通- 最 高5.00
- 今 開4.90
- 成交量 103.70万股
- 最 低 4.40
- 昨 收 5.03
- 總市值 1.54亿
- 52周最高 8.95
- 市盈率 靜 --
- 換手率 3.17%
- 52周最低 0.8801
- 委 比 53.85%
- 總股本 3272.09万
- 歷史最高 20.00
- 量 比 0.90
- 振 幅 11.93%
- 歷史最低 0.8801
- 每 手 1
- 風險率 4.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
10-01 20:13
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
09-26 20:10
美股牛股 | 中概“妖股”恒峰科技上市累涨640%！锂矿股Lithium再涨22%，特朗普政府拟购买10%股权
中概股“妖股”恒峰科技上市累涨640%！公司在香港提供管理咨询、资产管理服务；锂矿股Lithium再涨22%，特朗普政府拟购买10%股权>>
09-26 17:08
美股大行评级 | 星展银行上调百度评级至"买入"，目标价177美元；多家机构上调Guardant Health(GH)目标价最高至80美元
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12美元升至12.5美元；Oppenheimer：维持Immuneering"跑赢大市"评级，目标价从21美元升至30美元
09-26 09:45
PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles
PepGen Inc. (NASDAQ: PEPG) stock is skyrocketing on Thursday, with a session volume of 53.04 million compared to the average volume of 943.2 thousand as per data from Benzinga Pro.
09-25 21:46
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket
Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritten public offering of common stock and pre-funded warrants.
09-25 18:11
Accenture, Stitch Fix And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading mixed this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
09-25 17:26
Why Did PepGen Shares Surge 120% After Hours?
PepGen shares surged 119.55% after announcing an underwritten public offering, with proceeds to support clinical trials for neuromuscular diseases.
09-25 13:48
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
PepGen Launches Underwritten Public Offering Of Common Stock; No Terms Disclosed
PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,
09-25 04:23
